Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) had its price target increased by Piper Sandler from $16.00 to $19.00 in a report released on Tuesday, The Fly reports. Separately, StockNews.com upgraded shares of Ironwood Pharmaceuticals from a buy rating to a strong-buy rating in a research report on Wednesday, May 17th. Ironwood Pharmaceuticals Trading Up 0.7 […]
Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) gapped down prior to trading on Monday . The stock had previously closed at $10.47, but opened at $10.25. Ironwood Pharmaceuticals shares last traded at $10.02, with a volume of 1,541,079 shares. Analyst Ratings Changes Separately, StockNews.com upgraded shares of Ironwood Pharmaceuticals from a “buy” rating […]
Tocqueville Asset Management L.P. boosted its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) by 3.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 29,641 shares of the biotechnology company’s stock after buying an additional 1,110 shares during the period. Tocqueville Asset Management […]